These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 752447)

  • 1. The use of mixtures of topical corticosteroids as a mechanism for improving total drug bioavailability: a preliminary report.
    Poulsen BJ; Chowhan ZT; Pritchard R; Katz M
    Curr Probl Dermatol; 1978; 7():107-20. PubMed ID: 752447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Penetration of various labelled steroids into human skin].
    Zesch A; Schaefer H
    Arzneimittelforschung; 1973 Mar; 23(3):415-9. PubMed ID: 4740126
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative studies in man on the percutaneous absorption of diflucortolone valerate, betamethasone-17-valerate, beclomethasone dipropionate and fluocinolone acetonide].
    Täuber VU; Amin M; Fuchs P; Speck U
    Arzneimittelforschung; 1976; 26(7b):1492-5. PubMed ID: 1036945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Skin absorption of steroid preparations].
    Kibler-Nockowska M
    Przegl Dermatol; 1979; 66(4):427-31. PubMed ID: 386435
    [No Abstract]   [Full Text] [Related]  

  • 5. [The penetration of drugs into the skin].
    Schaefer H; Zesch A; Stüttgen G
    Hautarzt; 1975 Sep; 26(9):449-51. PubMed ID: 1102493
    [No Abstract]   [Full Text] [Related]  

  • 6. The absorption of topical corticosteroids, with particular reference to percutaneous absorption in infancy and childhood.
    Keipert JA
    Med J Aust; 1971 May; 1(19):1021-5. PubMed ID: 4930660
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimization of bioavailability of topical steroids: non-occluded penetration enhancers under thermodynamic control.
    Bennett SL; Barry BW; Woodford R
    J Pharm Pharmacol; 1985 May; 37(5):298-304. PubMed ID: 2862236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of drugs through the skin.
    Stoughton RB
    Dermatologica; 1976; 152 Suppl 1():27-36. PubMed ID: 133842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vehicle design for a new topical steroid, fluocinonide.
    Ostrenga J; Haleblian J; Poulsen B; Ferrell B; Mueller N; Shastri S
    J Invest Dermatol; 1971 May; 56(5):392-9. PubMed ID: 5556528
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of hydrocolloid patch composition on the bioavailability of triamcinolone acetonide in humans.
    Martin GP; Ladenheim D; Marriott C; Hollingsbee DA; Brown MB
    Drug Dev Ind Pharm; 2000 Jan; 26(1):35-43. PubMed ID: 10677808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind controlled comparison of generic and trade-name topical steroids using the vasoconstriction assay.
    Olsen EA
    Arch Dermatol; 1991 Feb; 127(2):197-201. PubMed ID: 1990984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation in treatment of oral lichen planus with topical fluocinolone acetonide: a 2-year follow-up.
    Thongprasom K; Luengvisut P; Wongwatanakij A; Boonjatturus C
    J Oral Pathol Med; 2003 Jul; 32(6):315-22. PubMed ID: 12787037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of polyoxypropylene 15 stearyl ether and propylene glycol on percutaneous penetration rate of diflorasone diacetate.
    Turi JS; Danielson D; Woltersom JW
    J Pharm Sci; 1979 Mar; 68(3):275-80. PubMed ID: 423113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of vehicle composition. I. Relationship between topical vehicle composition, skin penetrability, and clinical efficacy.
    Ostrenga J; Steinmetz C; Poulsen B
    J Pharm Sci; 1971 Aug; 60(8):1175-9. PubMed ID: 5127090
    [No Abstract]   [Full Text] [Related]  

  • 15. Various vagaries of vasoconstriction.
    Burdick KH
    Arch Dermatol; 1974 Aug; 110(2):238-42. PubMed ID: 4855376
    [No Abstract]   [Full Text] [Related]  

  • 16. [Remarks on the percutaneous absorption of corticoids].
    Rimbaud P; Meynadier J
    Ann Dermatol Syphiligr (Paris); 1968; 95(3):263-7. PubMed ID: 5697207
    [No Abstract]   [Full Text] [Related]  

  • 17. [Skin vasoconstriction assay in the evaluation of topical corticosteroids in man. General problems and results obtained in a series of tests (author's transl)].
    Weirich EG; Lutz U
    Dermatologica; 1973; 147(6):353-75. PubMed ID: 4788215
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemical stability of fluocinolone acetonide ointment and fluocinonide cream diluted in emollient bases.
    Barnes AR; Chapman SB; Irwin WJ
    J Clin Pharm Ther; 1995 Oct; 20(5):265-9. PubMed ID: 8576293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin.
    Schwarb FP; Imanidis G; Smith EW; Haigh JM; Surber C
    Pharm Res; 1999 Jun; 16(6):909-15. PubMed ID: 10397613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrocortisone 17-butyrate: a new topical corticosteroid preliminary report.
    Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS
    Drugs; 1976; 12(4):249-57. PubMed ID: 786608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.